Stock Scorecard



Stock Summary for Oncology Institute Inc (The) (TOI) - $3.85 as of 10/8/2025 4:47:41 PM EST

Total Score

8 out of 30

Safety Score

17 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TOI

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TOI

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TOI

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for TOI

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for TOI (17 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for TOI

The Oncology Institute ( TOI ) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner 9/18/2025 1:35:00 PM
The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos - Oncology Institute ( NASDAQ:TOIIW ) , Oncology Institute ( NASDAQ:TOI ) 9/2/2025 8:05:00 PM
Oncology Institute Sales Jump 22 Percent 8/13/2025 11:06:00 PM
Oncology Institute TOI Earnings Call Transcript 8/13/2025 10:04:00 PM
The Oncology Institute Q2 Revenue Surges 8/13/2025 10:00:00 PM
The Oncology Institute Names Kristin England as Chief Administrative Officer 7/14/2025 8:05:00 PM
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada - Oncology Institute ( NASDAQ:TOIIW ) , Oncology Institute ( NASDAQ:TOI ) 6/30/2025 8:05:00 PM
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada 6/30/2025 8:05:00 PM
Beyond Oil Announces Publication of Expert Medical Opinion by Prof. Ilan Ron, Specialist in Clinical and Radiation Oncology, Regarding the Risks Associated with Exposure to Frying Oils as Contributors to Neoplastic Mutations in Body Tissue 6/18/2025 12:30:00 PM
Beyond Oil Announces Publication of Expert Medical Opinion by Prof. Ilan Ron, Specialist in Clinical and Radiation Oncology, Regarding the Risks Associated with Exposure to Frying Oils as Contributors to Neoplastic Mutations in Body Tissue - Beyond Oil ( OTC:BEOLF ) 6/18/2025 12:30:00 PM

Financial Details for TOI

Company Overview

Ticker TOI
Company Name Oncology Institute Inc (The)
Country USA
Description N/A
Sector Name HEALTHCARE
Industry Name MEDICAL CARE FACILITIES
Most Recent Quarter 6/30/2025
Next Earnings Date 11/12/2025

Stock Price History

Last Day Price 3.85
Price 4 Years Ago 0.00
Last Day Price Updated 10/8/2025 4:47:41 PM EST
Last Day Volume 1,256,646
Average Daily Volume 1,662,753
52-Week High 4.50
52-Week Low 0.13
Last Price to 52 Week Low 2,861.54%

Valuation Measures

Trailing PE N/A
Industry PE 27.75
Sector PE 41.70
5-Year Average PE -4.31
Free Cash Flow Ratio 12.03
Industry Free Cash Flow Ratio 33.08
Sector Free Cash Flow Ratio 30.25
Current Ratio Most Recent Quarter 1.62
Total Cash Per Share 0.32
Book Value Per Share Most Recent Quarter -0.10
Price to Book Ratio 0.76
Industry Price to Book Ratio 18.22
Sector Price to Book Ratio 32.02
Price to Sales Ratio Twelve Trailing Months 0.84
Industry Price to Sales Ratio Twelve Trailing Months 1.16
Sector Price to Sales Ratio Twelve Trailing Months 20.22
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 93,505,000
Market Capitalization 359,994,250
Institutional Ownership 43.04%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 22.16%
Reported EPS 12 Trailing Months -0.67
Reported EPS Past Year -0.36
Reported EPS Prior Year -0.71
Net Income Twelve Trailing Months -65,889,000
Net Income Past Year -64,663,000
Net Income Prior Year -83,068,000
Quarterly Revenue Growth YOY 21.50%
5-Year Revenue Growth 20.41%
Operating Margin Twelve Trailing Months -9.36%

Balance Sheet

Total Cash Most Recent Quarter 30,292,000
Total Cash Past Year 49,669,000
Total Cash Prior Year 33,488,000
Net Cash Position Most Recent Quarter -44,731,000
Net Cash Position Past Year -43,462,000
Long Term Debt Past Year 93,131,000
Long Term Debt Prior Year 86,826,000
Total Debt Most Recent Quarter 75,023,000
Equity to Debt Ratio Past Year 0.04
Equity to Debt Ratio Most Recent Quarter -0.14
Total Stockholder Equity Past Year 3,589,000
Total Stockholder Equity Prior Year 57,025,000
Total Stockholder Equity Most Recent Quarter -8,985,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -13,878,000
Free Cash Flow Per Share Twelve Trailing Months -0.15
Free Cash Flow Past Year -30,327,000
Free Cash Flow Prior Year -40,882,000

Options

Put/Call Ratio 0.08
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.11
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 10/7/2025 11:06:23 AM EST